Cite
HARVARD Citation
Pomponio, G. et al. (2018). Sustained clinical response after single course of rituximab as first-line monotherapy in adult-onset asthma and periocular xanthogranulomas syndrome associated with IgG4-related disease. Medicine. 97 (26), p. . [Online].